NYSE:PFEPharmaceuticals
Why Pfizer (PFE) Is Up 5.2% After Raising 2026 Guidance Despite a Q2 Net Loss
In the second quarter of 2026, Pfizer reported revenue of US$15,034 million, up from US$14,653 million a year earlier, but swung from net income of US$2,910 million to a net loss of US$248 million after recording US$4.30 billion in non-cash intangible asset impairments.
Despite these impairments, Pfizer raised its 2026 revenue guidance midpoint to US$61.50 billion and highlighted encouraging late-stage pipeline progress, including positive Phase 3 results for its vitiligo therapy...